Introduction of KCNH6
KCNH6 is encoded by KCNH6 gene. It belongs to the ERG subfamily of voltage-gated potassium channels which has been extensively studied during the past few decades because it offers numerous possibilities for therapeutic applications. KCNH6 (ccErg2) is the main isoform of the Kv11 potassium channel family with relative transcript levels of 98.9% and 99.6% in crucian carp atrium and ventricle, respectively. Meanwhile, recent studies have identified that KCNH6 is associated with many diseases, such as Charcot-Marie-Tooth disease, Demyelinating, Type 1D and Charcot-Marie-Tooth disease, Axonal, Type 2F, which indicates KCNH6 could be a biomarker in the clinic.
|Basic Information of KCNH6|
|Protein Name||Potassium voltage-gated channel subfamily H member 6|
|Aliases||ERG-2, ERG2, HERG2, Kv11.2, hERG-2,|
|Organism||Homo sapiens (Human)|
Function of KCNH6 Membrane Protein
KCNH6 is a member of pore-forming (alpha) subunit. It plays a vital role in many biological processes, include regulating neurotransmitter release, heart rate, and insulin secretion. Previous studies have shown that it has high expression in several tissues, such as kidney, small intestine, and prostate, which suggests it could be involved in tissue regulation and progression. In addition, studies have confirmed that KCNH6 is expressed throughout the brain of rats, including the olfactory bulb, cerebral cortex, hippocampus, hypothalamus, and cerebellum.
Fig.1 Sequence and structure of the C-terminal region of ERG channels. (Gardner, 2015)
Application of KCNH6 Membrane Protein in Literature
This article analyses the expression levels of these epilepsy-related genes (KCNA2, KCNB1, KCND2, KCNH1, KCNH6, KCNJ10, KCNMA1, KCNQ2, KCNQ3, and KCNT1) and identifies the potential mechanisms of the development of seizures and epilepsy in patients. These results show that these genes may be targets for clinical therapy.
This article reports that the marked difference between fish and mammalian Erg1/2, and the data reveals that the Erg1/2 model in different species may affect the function of drug sensitivity.
Authors in this group focus on the role of lysine-rich leukemia protein during the HTLV-1 Tax oncogene-induced transactivation. These results demonstrate that a novel ELL-dependent transactivation induced by immediate early genes Tax.
This article examines the expression levels of Voltage-gated potassium channels (VGPCs) related family genes in different species such as human, rat, mice. The data illustrate that KCNH subfamily plays an important role in this family.
This article evaluates the expression of genes related with insulin secretion such as transmembrane proteins genes (CACNA1A, KCNH6, KCNJ10, NOTCH2, RYR3, SCN8A, TRPV3, TRPC5), cytosolic and mitochondrial enzymes genes. These results suggest that mutations in those genes may contribute to the development of congenital hyperinsulinism of infancy.
KCNH6 Preparation Options
To obtain the soluble and functional target protein, the versatile Magic™ membrane protein production platform in Creative Biolabs enables many flexible options, from which you can always find a better match for your particular project. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-KCNH6 antibody development services.
As a forward-looking research institute as well as a leading custom service provider in the field of membrane protein, Creative Biolabs has won good reputation among our worldwide customers for successfully accomplishing numerous challenging projects including generation of many functional membrane proteins. Please feel free to contact us for more information.
All listed customized services & products are for research use only, not intended for pharmaceutical, diagnostic, therapeutic or any in vivo human use.